GLP-1 receptor agonists, such as semaglutide and tirzepatide, have transformed the landscape of metabolic care and weight management. By mimicking natural incretin hormones, these medications slow gastric emptying, regulate appetite signals, and support healthy blood sugar utilization. However, the deliberate delay in digestive transit time can often trigger noticeable gastrointestinal shifts, including occasional bloating, fullness, irregular bowel movements, and general…

Dental Care

Health Insights

Hair loss

Fitness

Featured Post